FI945598A - Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi - Google Patents

Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi Download PDF

Info

Publication number
FI945598A
FI945598A FI945598A FI945598A FI945598A FI 945598 A FI945598 A FI 945598A FI 945598 A FI945598 A FI 945598A FI 945598 A FI945598 A FI 945598A FI 945598 A FI945598 A FI 945598A
Authority
FI
Finland
Prior art keywords
treatment
quaternary nitrogen
phosphonate compounds
phosphate metabolism
abnormal calcium
Prior art date
Application number
FI945598A
Other languages
English (en)
Swedish (sv)
Other versions
FI945598A0 (fi
Inventor
Frank Hallock Ebetino
Susan Mary Kaas
Marion David Francis
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Publication of FI945598A0 publication Critical patent/FI945598A0/fi
Publication of FI945598A publication Critical patent/FI945598A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3821Acyclic saturated acids which can have further substituents on alkyl substituted by B, Si, P or a metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI945598A 1992-05-29 1994-11-28 Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi FI945598A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89135592A 1992-05-29 1992-05-29
PCT/US1993/004469 WO1993024494A1 (en) 1992-05-29 1993-05-11 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism

Publications (2)

Publication Number Publication Date
FI945598A0 FI945598A0 (fi) 1994-11-28
FI945598A true FI945598A (fi) 1995-01-25

Family

ID=25398040

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945598A FI945598A (fi) 1992-05-29 1994-11-28 Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi

Country Status (16)

Country Link
EP (1) EP0642517A1 (fi)
JP (1) JPH07507305A (fi)
KR (1) KR950701927A (fi)
CN (1) CN1085906A (fi)
AU (1) AU675224B2 (fi)
CA (1) CA2136819A1 (fi)
CZ (1) CZ296694A3 (fi)
FI (1) FI945598A (fi)
HU (1) HUT69732A (fi)
IL (1) IL105831A0 (fi)
MX (1) MX9303245A (fi)
NZ (1) NZ252587A (fi)
RU (1) RU94046139A (fi)
SK (1) SK144594A3 (fi)
WO (1) WO1993024494A1 (fi)
ZA (1) ZA933758B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728650A (en) * 1993-10-07 1998-03-17 Zeneca Limited Herbicidal aza bisphosphonic acids and compositions containing the same
IL115041A0 (en) * 1995-08-23 1995-12-08 Yissum Res Dev Co Novel bisphosphonates process for their preparation and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE4011777A1 (de) * 1989-04-14 1990-10-18 Ciba Geigy Ag N-trisubstituierte aminoalkandiphosphonsaeuren

Also Published As

Publication number Publication date
CZ296694A3 (en) 1995-12-13
FI945598A0 (fi) 1994-11-28
HU9403406D0 (en) 1995-02-28
IL105831A0 (en) 1993-09-22
NZ252587A (en) 1997-02-24
RU94046139A (ru) 1996-09-27
AU4245393A (en) 1993-12-30
JPH07507305A (ja) 1995-08-10
KR950701927A (ko) 1995-05-17
HUT69732A (en) 1995-09-28
EP0642517A1 (en) 1995-03-15
MX9303245A (es) 1994-05-31
WO1993024494A1 (en) 1993-12-09
CA2136819A1 (en) 1993-12-09
AU675224B2 (en) 1997-01-30
ZA933758B (en) 1994-01-20
SK144594A3 (en) 1995-07-11
CN1085906A (zh) 1994-04-27

Similar Documents

Publication Publication Date Title
ZA933763B (en) Novel quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental caculus and plaque.
FI945595A (fi) Tiosubstituoituja typpipitoisia heterosyklisiä fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
EP0814814A4 (en) METHODS OF TREATING THROMBOSIS
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
EP0449405A3 (en) Use of bisphosphonic acids for the treatment of calcium metabolism disorders
DK297585A (da) 1-methylcarbapenemer med externt alkylerede mono- eller bicycliske kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
EP0510503A3 (en) Process for the treatment of surfaces
IL115793A0 (en) Process for the manufacture of n-phosphonomethylglycine or its salts
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
FI945594A (fi) Tiosubstituoituja syklisiä fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
NO932860L (no) Fremgangsmaate for fremstilling av kalsium-L-askorbat-2-fosfat
FI945598A0 (fi) Kvartäärisiä typpipitoisia fosfonaattiyhdisteitä epänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
HU9403586D0 (en) Process for the remoual of phosphorous
NO944514D0 (no) Kvarternære nitrogen-inneholdende fosfonatforbindelser for behandling av abnormal kalsium- og fosfatmetabolisme
NO982562D0 (no) Sammensetning for behandling av smerte
EP0440249A3 (en) Ethanolamine for the treatment of keloid
NO933892D0 (no) Fremgangsmaate for behandling av metallkloridinneholdende avfall
ZA933765B (en) Novel quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methodsfor treating abnormal calcium and phosphate metabolism.
GB2262886B (en) N-channel calcium antagonists useful for treating bronchial diseases
GB9424471D0 (en) Treatment of emesis
IL109034A0 (en) Pharmaceutical compositions containing triazine compounds for the treatment of impaired memory
NO945058D0 (no) Anvendelse av fosfonater for behandling av osteoporose
SE9303740D0 (sv) Farmaceutisk komposition
IL105714A0 (en) Oral dosage forms of risedronate
ZA931221B (en) The use of hymenialdisine compounds for treating diseases requiring inhibition of protein Kinase C